Seroconversion to seasonal influenza viruses after A(H1N1) pdm09 virus infection, Quebec, Canada

Emerging Infectious Diseases

Volumn 18, Issue 7, 2012, Pages 1132-1134

  Baz, Mariana ^a,b   Papenburg, Jesse ^a   Hamelin, Marie Eve ^a   Ouakki, Manale ^c   Skowronski, Danuta M ^d   Serres, Gaston ^c   Boivin, Guy ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^d BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CROSS REACTING ANTIBODY; VIRUS HEMAGGLUTININ;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; CANADA; CHILD; CLINICAL FEATURE; HUMAN; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H1N1 PDM09; INFLUENZA VIRUS A H3N2; MAJOR CLINICAL STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SEASONAL INFLUENZA; SEROCONVERSION; SEROLOGY; VIRUS NEUTRALIZATION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CHILD; CROSS PROTECTION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; PANDEMICS; QUEBEC; SEASONS; YOUNG ADULT;

EID: 84862554454     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1807.111680     Document Type: Article

References (15)

1. Glezen WP. How did the 2008-2009 seasonal influenza vaccine affect the pandemic? Clin Infect Dis. 2010;51:1380-2. http://dx.doi.org/10.1086/657312
2. Cowling BJ, Ng S, Ma ES, Cheng CK, Wai W, Fang VJ, et al. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. Clin Infect Dis. 2010;51:1370-9. http://dx.doi.org/10.1086/657311
3. Gioia C, Castilletti C, Tempestilli M, Piacentini P, Bordi L, Chiappini R, et al. Cross-subtype immunity against avian influenza in persons recently vaccinated for influenza. Emerg Infect Dis. 2008;14:121-8. http://dx.doi.org/10.3201/eid1401.061283
4. Van Reeth K, Braeckmans D, Cox E, Van Borm S, van den Berg T, Goddeeris B, et al. Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus. Vaccine. 2009;27:6330-9. http://dx.doi.org/10.1016/j.vaccine.2009.03.021
5. Papenburg J, Baz M, Hamelin ME, Rheaume C, Carbonneau J, Ouakki M, et al. Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratory-confirmed secondary attack rates and evidence of asymptomatic infections. Clin Infect Dis. 2010;51:1033-41. http://dx.doi.org/10.1086/656582
6. LeBlanc JJ, Li Y, Bastien N, Forward KR, Davidson RJ, Hatchette TF. Switching gears for an influenza pandemic: validation of a duplex reverse transcriptase PCR assay for simultaneous detection and confirmatory identification of pandemic (H1N1) 2009 influenza virus. J Clin Microbiol. 2009;47:3805-13. http://dx.doi.org/10.1128/JCM.01344-09
7. Fouchier RA, Bestebroer TM, Herfst S, Van Der Kemp L, Rimmelzwaan GF, Osterhaus AD. Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene. J Clin Microbiol. 2000;38:4096-101.
8. Papenburg J, Baz M, Hamelin ME, Rheaume C, Carbonneau J, Ouakki M, et al. Evaluation of serological diagnostic methods for the 2009 pandemic influenza A (H1N1) virus. Clin Vaccine Immunol. 2011;18:520-2. http://dx.doi.org/10.1128/CVI.00449-10
9. Perera RA, Riley S, Ma SK, Zhu HC, Guan Y, Peiris JS. Seroconversion to pandemic (H1N1) 2009 virus and cross-reactive immunity to other swine influenza viruses. Emerg Infect Dis. 2011;17:1897-9.
10. Wrammert J, Koutsonanos D, Li GM, Edupuganti S, Sui J, Morrissey M, et al. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med. 2011;208:181-93. http://dx.doi.org/10.1084/jem.20101352
11. Corti D, Suguitan AL Jr, Pinna D, Silacci C, Fernandez-Rodriguez BM, Vanzetta F, et al. Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J Clin Invest. 2010;120:1663-73. http://dx.doi.org/10.1172/JCI41902
12. Greenbaum JA, Kotturi MF, Kim Y, Oseroff C, Vaughan K, Salimi N, et al. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci U S A. 2009;106:20365-70. http://dx.doi.org/10.1073/pnas.0911580106
13. Skowronski DM, De Serres G, Crowcroft NS, Janjua NZ, Boulianne N, Hottes TS, et al. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during spring-summer 2009: four observational studies from Canada. PLoS Med. 2010;7:e1000258. http://dx.doi.org/10.1371/journal.pmed.1000258
14. Janjua NZ, Skowronski DM, Hottes TS, Osei W, Adams E, Petric M, et al. Seasonal influenza vaccine and increased risk of pandemic A/H1N1-related illness: first detection of the association in British Columbia, Canada. Clin Infect Dis. 2010;51:1017-27. http://dx.doi.org/10.1086/656586
15. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009;361:1945-52. http://dx.doi.org/10.1056/NEJMoa0906453